- Home
- STN vs ITCI Comparison
STN vs ITCI Comparison
Compare STN & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STN
- ITCI
- Stock Information
- Founded
- STN 1954
- ITCI 2002
- Country
- STN Canada
- ITCI United States
- Employees
- STN N/A
- ITCI N/A
- Industry
- STN Military/Government/Technical
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- STN Consumer Discretionary
- ITCI Health Care
- Exchange
- STN Nasdaq
- ITCI Nasdaq
- Market Cap
- STN 9.3B
- ITCI 8.0B
- IPO Year
- STN N/A
- ITCI N/A
- Fundamental
- Price
- STN $80.74
- ITCI $76.13
- Analyst Decision
- STN Strong Buy
- ITCI Strong Buy
- Analyst Count
- STN 2
- ITCI 11
- Target Price
- STN $105.00
- ITCI $97.00
- AVG Volume (30 Days)
- STN 146.2K
- ITCI 456.3K
- Earning Date
- STN 11-07-2024
- ITCI 10-31-2024
- Dividend Yield
- STN 0.77%
- ITCI N/A
- EPS Growth
- STN 14.50
- ITCI N/A
- EPS
- STN 2.22
- ITCI N/A
- Revenue
- STN $3,961,860,228.00
- ITCI $564,526,000.00
- Revenue This Year
- STN $16.06
- ITCI $46.60
- Revenue Next Year
- STN $9.44
- ITCI $37.06
- P/E Ratio
- STN $36.06
- ITCI N/A
- Revenue Growth
- STN 13.02
- ITCI 54.31
- 52 Week Low
- STN $59.55
- ITCI $45.50
- 52 Week High
- STN $88.42
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- STN 42.56
- ITCI 50.28
- Support Level
- STN $76.03
- ITCI $74.46
- Resistance Level
- STN $85.40
- ITCI $76.98
- Average True Range (ATR)
- STN 1.45
- ITCI 1.75
- MACD
- STN -0.00
- ITCI 0.19
- Stochastic Oscillator
- STN 41.13
- ITCI 54.78
About STN Stantec Inc
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. The company is geographically diversified in three regional operating units namely Canada, United States and Global, offering similar services across all regions. The company offers services in various sectors across the project life cycle through five business operating units infrastructure, water, buildings, environmental services, and energy and resources. The company provides professional services in all phases of the project life cycle: planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.